Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Chawla

Showing results (31-40 of 171) with videos related to

Pageof 18
Sort By:
Molecular and Clinical Oncology|June 8, 2017
Rexin-G<sup>®</sup>, a tumor-targeted retrovector for malignant peripheral nerve sheath tumor: A case reportSeth Kim, Noah Federman, Erlinda M Gordon, et al.
International Journal of Oral and Maxillofacial Surgery|May 24, 2018
Corseting: a new technique for the management of diffuse venous malformations in the head and neck regionS C Nair, J P Chawla, S S Shroff, et al.
Abdominal Radiology (New York)|March 2, 2017
Primary perivascular epithelioid cell tumors of the liver: CT/MRI findings and clinical outcomesMartin E O'Malley, Tanya P Chawla, Lisa P Lavelle, et al.
Meat Science|November 9, 2011
Influence of low dose irradiation on the quality of fresh buffalo meat stored at 0-3°CG N Naik, P Paul, S P Chawla, et al.
Frontiers in Molecular Medicine|August 1, 2024
Phase I-II study using DeltaRex-G, a tumor-targeted retrovector encoding a cyclin G1 inhibitor for metastatic carcinoma of breastHoward W Bruckner, Sant P Chawla, Nadezhda Omelchenko, et al.
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|March 2, 2010
The role of cross-sectional imaging in male infertility: a pictorial reviewKartik S Jhaveri, Waseem Mazrani, Tanya P Chawla, et al.
Journal of Postgraduate Medicine|July 1, 1992
Facial nerve involvement in pseudotumor cerebriS K Bakshi, J L Oak, K P Chawla, et al.
Molecular and Clinical Oncology|August 14, 2018
Cell cycle checkpoint control: The cyclin G1/Mdm2/p53 axis emerges as a strategic target for broad-spectrum cancer gene therapy - A review of molecular mechanisms for oncologistsErlinda M Gordon, Joshua R Ravicz, Seiya Liu, et al.
Bioresource Technology|September 13, 2005
Studies on the development of functional powder from citrus peelH J Kang, S P Chawla, C Jo, et al.
Clinical Nuclear Medicine|December 22, 2007
F-18 FDG PET and PET/CT evaluation of response to chemotherapy in bone and soft tissue sarcomasAndrei Iagaru, Rinat Masamed, Sant P Chawla, et al.
Pageof 18

Showing results (31-40 of 171) with videos related to

Sort By:
Pageof 18
Molecular and Clinical Oncology|June 8, 2017
Rexin-G<sup>®</sup>, a tumor-targeted retrovector for malignant peripheral nerve sheath tumor: A case reportSeth Kim, Noah Federman, Erlinda M Gordon, et al.
International Journal of Oral and Maxillofacial Surgery|May 24, 2018
Corseting: a new technique for the management of diffuse venous malformations in the head and neck regionS C Nair, J P Chawla, S S Shroff, et al.
Abdominal Radiology (New York)|March 2, 2017
Primary perivascular epithelioid cell tumors of the liver: CT/MRI findings and clinical outcomesMartin E O'Malley, Tanya P Chawla, Lisa P Lavelle, et al.
Meat Science|November 9, 2011
Influence of low dose irradiation on the quality of fresh buffalo meat stored at 0-3°CG N Naik, P Paul, S P Chawla, et al.
Frontiers in Molecular Medicine|August 1, 2024
Phase I-II study using DeltaRex-G, a tumor-targeted retrovector encoding a cyclin G1 inhibitor for metastatic carcinoma of breastHoward W Bruckner, Sant P Chawla, Nadezhda Omelchenko, et al.
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|March 2, 2010
The role of cross-sectional imaging in male infertility: a pictorial reviewKartik S Jhaveri, Waseem Mazrani, Tanya P Chawla, et al.
Journal of Postgraduate Medicine|July 1, 1992
Facial nerve involvement in pseudotumor cerebriS K Bakshi, J L Oak, K P Chawla, et al.
Molecular and Clinical Oncology|August 14, 2018
Cell cycle checkpoint control: The cyclin G1/Mdm2/p53 axis emerges as a strategic target for broad-spectrum cancer gene therapy - A review of molecular mechanisms for oncologistsErlinda M Gordon, Joshua R Ravicz, Seiya Liu, et al.
Bioresource Technology|September 13, 2005
Studies on the development of functional powder from citrus peelH J Kang, S P Chawla, C Jo, et al.
Clinical Nuclear Medicine|December 22, 2007
F-18 FDG PET and PET/CT evaluation of response to chemotherapy in bone and soft tissue sarcomasAndrei Iagaru, Rinat Masamed, Sant P Chawla, et al.
Pageof 18